Clover Health Investments, Corp. (CLOV)

NASDAQ: CLOV · Real-Time Price · USD
4.080
+0.010 (0.25%)
At close: Jan 17, 2025, 4:00 PM
4.060
-0.020 (-0.48%)
After-hours: Jan 17, 2025, 6:20 PM EST
0.25%
Market Cap 2.04B
Revenue (ttm) 2.12B
Net Income (ttm) -91.39M
Shares Out 501.11M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,412,807
Open 4.080
Previous Close 4.070
Day's Range 4.015 - 4.130
52-Week Range 0.606 - 4.710
Beta 1.96
Analysts Buy
Price Target 5.00 (+22.55%)
Earnings Date Mar 11, 2025

About CLOV

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee. [Read more]

Sector Healthcare
Founded 2014
Employees 552
Stock Exchange NASDAQ
Ticker Symbol CLOV
Full Company Profile

Financial Performance

In 2023, Clover Health Investments's revenue was $2.04 billion, a decrease of -43.11% compared to the previous year's $3.58 billion. Losses were -$213.36 million, -37.17% less than in 2022.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for CLOV stock is "Buy." The 12-month stock price forecast is $5.0, which is an increase of 22.55% from the latest price.

Price Target
$5.0
(22.55% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Clover Health: Undervalued Turnaround Play With Promising SaaS Potential

Clover Health's revenue rose 8% in Q3 2024, driven by a 7% growth in Medicare Advantage premiums, despite exiting low-margin ACO REACH program. Cost control measures are paying off, with salaries and ...

4 days ago - Seeking Alpha

Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season

Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-sid...

Other symbols: ALHCCICNCOSCRUNH
4 days ago - Seeking Alpha

Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period

WILMINGTON, Del., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced a 27% year-over-year growth of its Med...

7 days ago - GlobeNewsWire

Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization

WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it has successfully deployed its Counterpart...

13 days ago - GlobeNewsWire

Insurtechs Shine On Wall Street In 2024 As Managed Care Struggles

Insurance technology companies were some of the best performing US insurers on Wall Street over the course of 2024, while the managed care sector had a less resilient year. Root Inc., Clover Health In...

27 days ago - Seeking Alpha

Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health

Clover Health's recent performance shows mixed results, with revenue growth but a significant share price drop, presenting a potential buying opportunity. Operational efficiency is improving, with bet...

4 weeks ago - Seeking Alpha

Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference

JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chie...

4 weeks ago - GlobeNewsWire

Clover Health: Balancing Innovation And Challenges

Clover Health Investments shows financial progress and challenges in 2024, with a focus on innovative Medicare Advantage plans and technology-driven healthcare solutions. The company achieved a 4.0 ra...

5 weeks ago - Seeking Alpha

Clover Health: Buy The Dip, Reap The Rewards

Clover's 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Clover continues to grow its topline and improve its bottom line performance. Clover's latest star rating upgra...

2 months ago - Seeking Alpha

Hippocratic AI Establishes a Healthcare Advisory Board Comprised of Seven Industry Visionaries and Business Leaders

PALO ALTO, Calif.--(BUSINESS WIRE)-- #GenAI--The board's purpose is to help guide the company on broad industry issues and complements Hippocratic AI's Physician and Nurse Advisory Councils.

2 months ago - Business Wire

Clover Health Investments, Corp. (CLOV) Q3 2024 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer...

2 months ago - Seeking Alpha

Clover Health's Rally: The Payoff Of A Profitable Pivot

Clover Health's pivot to profitability over growth following the divestiture of the non-insurance segment at the end of 2023 has led to significant earnings improvements. The newly launched Counterpar...

2 months ago - Seeking Alpha

Clover Health to Report Third Quarter 2024 Financial Results on November 6

FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after mar...

3 months ago - GlobeNewsWire

2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors

Company's affordable, benefit-rich flagship PPO plans now have 4 Star rating Company's affordable, benefit-rich flagship PPO plans now have 4 Star rating

3 months ago - GlobeNewsWire

Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025

Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member Experience Overall Star rating performance increase was d...

3 months ago - GlobeNewsWire

Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer

Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Hea...

3 months ago - GlobeNewsWire

Undercovered Dozen: Clover Health, Quipt, Vital Energy, STMicroelectronics +

The 'Undercovered' Dozen highlights 12 lesser-covered stocks with strong potential, aiming to provide investment ideas and spark community discussion. Dmytro Konovalov takes a look at the impacts of T...

Other symbols: STMVTLE
3 months ago - Seeking Alpha

Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations

New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients New Jersey Native Joseph Brand to Lead Operational Efficiency ...

4 months ago - GlobeNewsWire

The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest

FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, Counterpart Health, Inc . (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with The Iowa...

4 months ago - GlobeNewsWire

Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference

FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to ...

5 months ago - GlobeNewsWire

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Clover Health Investments posted its first profitable quarter as a public company and raised its full-year guidance in Q2. Clover Health's star rating increased by 0.5 stars, which could have a positi...

5 months ago - Seeking Alpha

Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Peter Kuipers - CFO Conference Call P...

5 months ago - Seeking Alpha

Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance

Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP l...

6 months ago - GlobeNewsWire

Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference

FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to ...

6 months ago - GlobeNewsWire

Clover Health to Report Second Quarter 2024 Financial Results on August 5

FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to great he...

6 months ago - GlobeNewsWire